Canaccord Genuity Downgrades Entellus Medical (ENTL) to Hold
Tweet
Share
E-mailGet Alerts ENTL Hot Sheet
Price: $10.05 +1.72%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Canaccord Genuity downgraded Entellus Medical (NASDAQ: ENTL) from Buy to Hold with a price target of $18.00 (from $22.00).
For an analyst ratings summary and ratings history on Entellus Medical click here. For more ratings news on Entellus Medical click here.
Shares of Entellus Medical closed at $15.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Northcoast Downgrades ScanSource (SCSC) to Neutral
- Macquarie Downgrades Northern Star Resources (NST:AU) (NESRF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
